MR/CT

Stay informed on state-of-the-art magnetic resonance and computed tomography. From ultra-high field imaging and AI-assisted reconstruction to spectral CT and functional MR, this category covers innovations that are pushing boundaries in speed, resolution, and diagnostic accuracy.

Radiology network ARISTRA adopts AB-CT breast CT technology

MedTech company AB-CT – Advanced Breast-CT, developer of the world’s only photon-counting breast CT, has partnered with radiology network ARISTRA.

Radiology Staffing Shortages: U.S. vs. UK Approaches

High vacancy rates continue to affect imaging departments. Data highlights the scale of the workforce shortage and measures to address the challenge.

Post-COVID CT Guidelines by International Radiology Consensus

Standardized guidelines for CT imaging in patients with residual lung abnormalities after COVID-19

Pediatric Imaging Market to Double in Value Over Next Decade

The pediatric imaging market is expected to more than double in value by 2034, made possible by advances in low-dose and AI-powered imaging.

FDA Grants Clearance for DeepHealth’s TechLive™

DeepHealth has received FDA 510(k) clearance for TechLive™, a vendor-agnostic remote scanning solution.

Neuroradiology Enables Targeted Treatment for Pulse-Synchronous Tinnitus

Advances in imaging techniques improve diagnosis and therapy options for vascular-related tinnitus symptoms

Bayer files for EU approval of gadoquatrane

Submitted dose corresponds to 60% gadolinium reduction compared to standard macrocyclic agents

Bayer Submits MRI Contrast Agent Gadoquatrane for FDA Review

If approved, gadoquatrane would become the lowest-dose macrocyclic gadolinium-based contrast agent available in the U.S. market.

Photo: Siemens Healthineers Presents MAGNETOM Flow RT Pro Edition for...

Siemens Healthineers Presents MAGNETOM Flow RT Pro Edition for Sustainable Magnetic Resonance Imaging in Radiation Therapy

Siemens Healthineers showcased its latest MRI system for radiation therapy at this year’s European Society for Radiotherapy and Oncology congress.

Bracco at ECR 2025: Innovations in Contrast Media and Sustainability

Bracco brings actionable solutions for ‘Planet Radiology’ to ECR 2025

Bayer at ECR 2025: Shaping Radiology with Contrast & AI

ECR 2025 Shines a Spotlight on Next-Generation Imaging Innovations

Photo: Positive results from Phase III study for Bayer’s investigational...

Positive results from Phase III study for Bayer’s investigational contrast agent gadoquatrane

SIRM2024: Giovagnoni on Oncology and the Olympics

SIRM2024: Bracco on New Contrast & Trends in EMEA